131 related articles for article (PubMed ID: 3427414)
1. The modulatory effect of neurotensin on [3H]dopamine release from rat nucleus accumbens slices is enhanced after chronic desipramine treatment.
Reyneke L; Russell VA; Taljaard JJ
Brain Res; 1987 Nov; 425(1):114-9. PubMed ID: 3427414
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic desipramine treatment on adrenoceptor modulation of [3H]dopamine release from rat nucleus accumbens slices.
Nurse B; Russell VA; Taljaard JJ
Brain Res; 1985 May; 334(2):235-42. PubMed ID: 3995319
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of chronic desipramine treatment on dopaminergic activity in the nucleus accumbens of the rat.
Reyneke L; Allin R; Russell VA; Taljaard JJ
Neurochem Res; 1989 Jul; 14(7):661-5. PubMed ID: 2571096
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices.
Nurse B; Russell VA; Taljaard JJ
Neurochem Res; 1988 May; 13(5):403-7. PubMed ID: 3165497
[TBL] [Abstract][Full Text] [Related]
5. Effect of ethanol on [3H]dopamine release in rat nucleus accumbens and striatal slices.
Russell VA; Lamm MC; Taljaard JJ
Neurochem Res; 1988 May; 13(5):487-92. PubMed ID: 3405375
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat.
Hétier E; Boireau A; Dubédat P; Blanchard JC
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):13-7. PubMed ID: 3368012
[TBL] [Abstract][Full Text] [Related]
7. Alpha 2 and beta-adrenoceptor agonists modulate [3H]dopamine release from rat nucleus accumbens slices: implications for research into depression.
Nurse B; Russell VA; Taljaard JJ
Neurochem Res; 1984 Sep; 9(9):1231-8. PubMed ID: 6095129
[TBL] [Abstract][Full Text] [Related]
8. The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitro.
Radhakishun FS; Stoof JC; Mulder AH; Versteeg DH; van Ree JM
Brain Res; 1987 Nov; 426(2):235-42. PubMed ID: 2961411
[TBL] [Abstract][Full Text] [Related]
9. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
Eur J Pharmacol; 1991 Mar; 195(1):63-73. PubMed ID: 2065713
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin modulates K(+)-stimulated dopamine release from the caudate-putamen but not the nucleus accumbens of mice with differential sensitivity to ethanol.
Duncan CC; Erwin VG
Alcohol; 1992; 9(1):23-9. PubMed ID: 1733422
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation.
Reyneke L; Russell VA; Taljaard JJ
Brain Res; 1990 Nov; 534(1-2):188-94. PubMed ID: 1981481
[TBL] [Abstract][Full Text] [Related]
12. Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization.
Heaulme M; Leyris R; Le Fur G; Soubrie P
Neuropharmacology; 1997 Oct; 36(10):1447-54. PubMed ID: 9423933
[TBL] [Abstract][Full Text] [Related]
13. Adrenocorticotropic hormone influences the development of adaptive changes in dopamine autoreceptors induced by chronic administration of desipramine.
Volosin M; Cancela LM; Laino C; Massei M; Molina VA
Neuropharmacology; 1991 Jul; 30(7):719-25. PubMed ID: 1656307
[TBL] [Abstract][Full Text] [Related]
14. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
15. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
Ichikawa J; Meltzer HY
Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
[TBL] [Abstract][Full Text] [Related]
17. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis.
Blaha CD; Coury A; Fibiger HC; Phillips AG
Neuroscience; 1990; 34(3):699-705. PubMed ID: 2352647
[TBL] [Abstract][Full Text] [Related]
18. Increased dopamine D2 receptor-mediated inhibition of [14C]acetylcholine release in the dorsomedial part of the nucleus accumbens.
Russell VA; Allin R; Lamm MC; Taljaard JJ
Neurochem Res; 1989 Sep; 14(9):877-81. PubMed ID: 2531849
[TBL] [Abstract][Full Text] [Related]
19. ACTH accelerates the attenuation of alpha 2-adrenoceptors response in nucleus accumbens following chronic desipramine.
Volosin M; Cancela LM; Molina VA
Methods Find Exp Clin Pharmacol; 1992 Apr; 14(3):189-92. PubMed ID: 1320714
[TBL] [Abstract][Full Text] [Related]
20. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens.
Kalivas PW; Duffy P
J Neurosci; 1990 Sep; 10(9):2940-9. PubMed ID: 1697899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
